Intravascular Radiofrequency Ablation of Sympathetic Nerves for the Treatment of Hepatocellular Carcinoma
NCT ID: NCT06694636
Last Updated: 2024-11-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
5 participants
INTERVENTIONAL
2024-02-01
2026-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Radiofrequency-responsive Layered Double Hydroxides for Enhanced Arterial Embolization and Thermal Immunotherapy in Hepatocellular Carcinoma
NCT06966986
Clinical Study of Targeted Cryoablation Therapy in the Treatment of Hepatic Carcinoma
NCT02969096
Treatment of Hepatocellular Carcinoma With Radiofrequency Ablation (RFA) Associated With Postoperative TACE
NCT00730860
Radiofrequency Ablation Combined With Transcatheter Arterial Chemoembolization Versus Radiofrequency Ablation Alone for Recurrent Hepatocellular Carcinoma
NCT01415063
Radiofrequency Ablation in Treating Patients With Unresectable Primary or Metastatic Liver Cancer
NCT00019604
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intravascular Radiofrequency Ablation of Sympathetic Nerves Group
Enrolled patients will receive Intravascular Radiofrequency Ablation of Sympathetic Nerves for the Treatment of Hepatocellular Carcinoma
endovascular radiofrequency ablation and desympathetic nerve surgery
endovascular radiofrequency ablation and desympathetic nerve surgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
endovascular radiofrequency ablation and desympathetic nerve surgery
endovascular radiofrequency ablation and desympathetic nerve surgery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Locally progressed or distant metastatic unresectable advanced HCC
* Progressed after second-line therapy
* Agree to participate in the study and sign the informed consent form
Exclusion Criteria
* Pregnant, lactating and planning to become pregnant
* Orthostatic hypotension
* Mixed liver cancer
* Intestinal obstruction
* Obvious bleeding tendencies and hematologic diseases
* Acute or severe systemic infection;
* Stroke or transient ischemic attack (TIA) within two weeks;
* Acute coronary syndrome within two weeks;
* Evaluated to be not suitable for this trial by investigators
25 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zhongda Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gao-jun Teng
Director of Interventional and Vascular Surgery Department
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gao-Jun Gao-Jun
Role: PRINCIPAL_INVESTIGATOR
Zhongda Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Zhongda Hospital
Nanjing, Jiangsu, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Teng
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024ZDSYLL167-P01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.